Conference Summaries: Day Three<BR> Sunday, September 29, 2002

The Body Covers: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy

Conference Summaries: Day Three
Sunday, September 29, 2002

HIV Pathogenesis
Coverage by Matthew R. Leibowitz, M.D.
- Human Alpha-Defensin-1, Alpha-Defensin-2, and Alpha-Defensin-3, Account for the Anti-HIV-1 Activity of CD8 Antiviral Factor (CAF) (Abstract 1192)
Antiretroviral Adherence and Pharmacokinetics
Coverage by Andrew T. Pavia, M.D.
- Lack of Alteration of Lopinavir and Ritonavir Trough Plasma Concentrations in HIV-Experienced Patients Treated With Kaletra and Tenofovir DF (Abstract H-1715)
HIV/Hepatitis Co-Infection
Coverage by Andrew T. Pavia, M.D.
- Relationships Between Nevirapine Plasma Levels, Chronic Hepatitis C, and the Development of Liver Toxicity (Abstract H-1731)
Coverage by Calvin J. Cohen, M.D., M.S.
- Tenofovir in the Treatment of Individuals Co-Infected With HIV and Hepatitis B (Abstract H-1740)
Science and ART: Optimizing the Use of NRTIs/NtRTIs in HIV Therapy
Coverage by Benjamin Young, M.D., Ph.D.

Previous Day's Sessions | Next Day's Sessions

Return to The Body's coverage of
The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy.

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.